ArticleBMC nutrition2026
Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Article in BMC nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06321211 (Development of a Novel Asian Mediterranean Diet and Its Acceptability in Non- Alcoholic Fatty Liver Disease), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development of a Novel Asian Mediterranean Diet and Its Acceptability in Non- Alcoholic Fatty Liver Disease (NAFLD)- a Pre-intervention Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeMetabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern in Asia, where dietary patterns differ significantly from those in Mediterranean regions. Although the Mediterranean Diet (MedDiet) is recommended for MASLD management, its adoption in Asia remains limited. This study aimed to develop a culturally adapted Asian Mediterranean Diet (AMED) and to evaluate its sensory acceptability among individuals with MASLD.
methodsA multi-phase methodology with a cross-sectional study design was employed, involving dietary mapping, portion standardization, recipe development, polyphenol profiling, and sensory evaluation. A 4-week AMED menu was formulated using culturally relevant ingredients and cooking methods. Nutritional composition and polyphenol content were determined. Sensory evaluation of 14 AMED dishes was conducted among 30 MASLD patients using a 7-point hedonic scale across six sensory domains.
resultsTwelve out of 14 dishes (85.7%) received favourable sensory scores (≥ 5). Texture was the strongest predictor of overall taste and acceptability (β = 0.83, p < 0.001). Polyphenol analysis revealed substantial antioxidant content across several dishes. The AMED menu met key MedDiet macronutrient targets and incorporated polyphenol-rich ingredients aligned with dietary recommendations for MASLD.
conclusionThe AMED represents a culturally adapted, nutritionally coherent, and sensory-acceptable interpretation of the MedDiet for Asian populations. These findings provide a foundation for future clinical trials and public health strategies targeting cardiometabolic diseases in Asian populations.
trial registrationNCT06321211; https://clinicaltrials.gov/study/NCT06321211?term=NCT06321211&rank=1 . Registration date: 30 March 2024.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.